These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 1329220

  • 1. Phase II and III studies with carboplatin in small cell lung cancer.
    Gatzemeier U, Hossfeld DK, Neuhauss R, Reck M, Achterrath W, Lenaz L.
    Semin Oncol; 1992 Feb; 19(1 Suppl 2):28-36. PubMed ID: 1329220
    [Abstract] [Full Text] [Related]

  • 2. Carboplatin in small cell lung cancer.
    Gatzemeier U, Hossfeld DK, Neuhauss R, Reck M, Achterrath W, Lenaz L.
    Semin Oncol; 1991 Feb; 18(1 Suppl 2):8-16. PubMed ID: 1846981
    [Abstract] [Full Text] [Related]

  • 3. Carboplatin/etoposide/vincristine therapy in small cell lung cancer.
    Gatzemeier U, von Pawel J, Laumen R, Hossfeld DK, Neuhauss R, Reck M, Lenaz L.
    Oncology; 1992 Feb; 49 Suppl 1():25-33. PubMed ID: 1323809
    [Abstract] [Full Text] [Related]

  • 4. Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer.
    Fetscher S, Brugger W, Engelhardt R, Kanz L, Hasse J, Frommhold H, Wenger M, Lange W, Mertelsmann R.
    Ann Oncol; 1997 Jan; 8(1):49-56. PubMed ID: 9093707
    [Abstract] [Full Text] [Related]

  • 5. Etoposide/vincristine-based chemotherapy with or without carboplatin in extensive-stage small cell lung cancer: a prospective randomized phase III trial.
    Gatzemeier U, Pawel JV, Laumen R, Hossfeld DK, Neuhauss R.
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):31-5. PubMed ID: 8052871
    [Abstract] [Full Text] [Related]

  • 6. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up.
    Sundstrøm S, Bremnes RM, Kaasa S, Aasebø U, Hatlevoll R, Dahle R, Boye N, Wang M, Vigander T, Vilsvik J, Skovlund E, Hannisdal E, Aamdal S, Norwegian Lung Cancer Study Group.
    J Clin Oncol; 2002 Dec 15; 20(24):4665-72. PubMed ID: 12488411
    [Abstract] [Full Text] [Related]

  • 7. Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin: quality of life and 6-years'-follow-up results from a randomised phase III trial.
    Reck M, von Pawel J, Macha HN, Kaukel E, Deppermann KM, Bonnet R, Ulm K, Hessler S, Gatzemeier U.
    Lung Cancer; 2006 Jul 15; 53(1):67-75. PubMed ID: 16713013
    [Abstract] [Full Text] [Related]

  • 8. Combination chemotherapy with carboplatin, etoposide, and vincristine as first-line treatment in small-cell lung cancer.
    Gatzemeier U, Hossfeld DK, Neuhauss R, Reck M, Achterrath W, Lenaz L.
    J Clin Oncol; 1992 May 15; 10(5):818-23. PubMed ID: 1314891
    [Abstract] [Full Text] [Related]

  • 9. Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 100 patients with small-cell lung cancer: a mature follow-up report.
    Fetscher S, Brugger W, Engelhardt R, Kanz L, Hasse J, Frommhold H, Lange W, Mertelsmann R.
    Ann Oncol; 1999 May 15; 10(5):561-7. PubMed ID: 10416006
    [Abstract] [Full Text] [Related]

  • 10. Experience of a German multicenter study group with ifosfamide in small cell lung cancer.
    Havemann K, Wolf M, Drings P, Hans K, Schroeder M, Holle R, Flechtner H, Goerg R, Becker H.
    Semin Oncol; 1989 Feb 15; 16(1 Suppl 3):9-18. PubMed ID: 2539648
    [Abstract] [Full Text] [Related]

  • 11. Superiority of cisplatin or carboplatin in combination with teniposide and vincristine in the induction chemotherapy of small-cell lung cancer. A randomized trial with 5 years follow up.
    Lassen U, Kristjansen PE, Osterlind K, Bergman B, Sigsgaard TC, Hirsch FR, Hansen M, Dombernowsky P, Hansen HH.
    Ann Oncol; 1996 Apr 15; 7(4):365-71. PubMed ID: 8805928
    [Abstract] [Full Text] [Related]

  • 12. Pilot study of cyclophosphamide-doxorubicin-vincristine-cisplatin-etoposide hybrid chemotherapy in small cell lung cancer.
    Ohnoshi T, Hiraki S, Ueoka H, Kiura K, Kamei H, Horiguchi T, Kodani T, Maeda T, Tabata M, Shibayama T.
    Cancer; 1993 Sep 01; 72(5):1597-601. PubMed ID: 8394202
    [Abstract] [Full Text] [Related]

  • 13. Randomized phase III trial of paclitaxel, etoposide, and carboplatin versus carboplatin, etoposide, and vincristine in patients with small-cell lung cancer.
    Reck M, von Pawel J, Macha HN, Kaukel E, Deppermann KM, Bonnet R, Ulm K, Hessler S, Gatzemeier U.
    J Natl Cancer Inst; 2003 Aug 06; 95(15):1118-27. PubMed ID: 12902441
    [Abstract] [Full Text] [Related]

  • 14. High-dose ifosfamide, carboplatin and etoposide with autologous peripheral blood progenitor cell transplantation for small-cell lung cancer.
    Bessho A, Ueoka H, Kiura K, Tabata M, Sunami K, Katayama Y, Yamane H, Hiraki A, Harada M.
    Anticancer Res; 1999 Aug 06; 19(1B):693-8. PubMed ID: 10216478
    [Abstract] [Full Text] [Related]

  • 15. Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapy.
    Tummarello D, Graziano F, Mari D, Cetto G, Pasini F, Antonio S, Isidori P, Gasparini S.
    Anticancer Res; 1994 Aug 06; 14(5B):2221-7. PubMed ID: 7840527
    [Abstract] [Full Text] [Related]

  • 16. [Chemotherapy of small cell bronchial cancer with a combination of carboplatin, vincristine and etoposide].
    Gatzemeier U, Achterrath W, Heckmayr M, Hossfeld DK, Neuhauss R, Reck M, Zschaber R.
    Pneumologie; 1990 Feb 06; 44 Suppl 1():584-5. PubMed ID: 2164203
    [Abstract] [Full Text] [Related]

  • 17. Etoposide combined with cyclophosphamide plus vincristine compared with doxorubicin plus cyclophosphamide plus vincristine and with high-dose cyclophosphamide plus vincristine in the treatment of small-cell carcinoma of the lung: a randomized trial of the Bristol Lung Cancer Study Group.
    Hong WK, Nicaise C, Lawson R, Maroun JA, Comis R, Speer J, Luedke D, Hurtubise M, Lanzotti V, Goodlow J.
    J Clin Oncol; 1989 Apr 06; 7(4):450-6. PubMed ID: 2538577
    [Abstract] [Full Text] [Related]

  • 18. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
    Lee YC, McCrystal MR, Christmas TI.
    N Z Med J; 1998 Nov 27; 111(1078):451-2, 453-4. PubMed ID: 9891564
    [Abstract] [Full Text] [Related]

  • 19. A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responses.
    Tummarello D, Mari D, Graziano F, Isidori P, Cetto G, Pasini F, Santo A, Cellerino R.
    Cancer; 1997 Dec 15; 80(12):2222-9. PubMed ID: 9404698
    [Abstract] [Full Text] [Related]

  • 20. Paclitaxel added to the cisplatin/etoposide regimen in extensive-stage small cell lung cancer -- the use of complete response rate as the primary endpoint in phase II trials.
    Dowlati A, Crosby L, Remick SC, Makkar V, Levitan N.
    Lung Cancer; 2001 May 15; 32(2):155-62. PubMed ID: 11325486
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.